K. Haworth

Statistics

Publications

Citations

103

H-Index

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

K. Haworth is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and heterocyclic chemistry.

Publications per year

1995–2002

Publications

<i>N</i>-Heteroaryl-2-phenyl-3-(benzyloxy)piperidines: A Novel Class of Potent Orally Active Human NK<sub>1</sub> Antagonists

T. Ladduwahetty, R. Baker, Margaret A. Cascieri et al. · Journal of Medicinal Chemistry · 1996 · 66 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Spirocyclic NK1 antagonists I: [4.5] and [5.5]-Spiroketals

Eileen M. Seward, Emma Carlson, Timothy Harrison et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 26 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7

Quinuclidine-based NK1 antagonists, the role of the benzhydryl

Christopher J. Swain, Tung M. Fong, K. Haworth et al. · Bioorganic & Medicinal Chemistry Letters · 1995 · 11 citations

Medicine, Medicinal Chemistry, Pharmacology +5

1–3 of 3